Neumora Therapeutics Shares Are Trading Higher. B of A Securities Maintained a Buy Rating on the Stock.

BenzingaJan 6 15:49 ET

B of A Securities Maintains Buy on Neumora Therapeutics, Lowers Price Target to $7

BenzingaJan 6 06:42 ET · Ratings

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA) and Idexx Laboratories (IDXX)

TipRanksJan 5 19:10 ET · Ratings

Trending Stocks as Wall Street Steps Into First Days of 2025 With Cautiousness

Seeking AlphaJan 4 12:09 ET

Sector Update: Health Care Stocks Higher Friday Afternoon

MT NewswiresJan 3 13:57 ET

Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk

Dow JonesJan 3 11:05 ET